Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Immunol. 2014 Jul 23;193(5):2373–2383. doi: 10.4049/jimmunol.1400486

FIGURE 3.

FIGURE 3

Synovial fibroblast products suppress IFN-β expression and responsiveness in TNF-stimulated macrophages. (A) Macrophages stimulated by TNF for 16 h with synovial fibroblasts in standard co-cultures, transwell cultures or with synovial fibroblast supernatants were analyzed for mRNA levels by qPCR. The supernatant media (FibTNF Supe) was collected from independent fibroblast cultures stimulated with TNF for 16 h. (B) qPCR mRNA analysis of macrophages cultured with control media (media) or supernatant media (FibTNF Supe) from fibroblasts independently cultured with TNF for 16h. Supernatants obtained from TNF-induced fibroblast cultures were first treated with Infliximab (Ifx) to eliminate TNF activity or isotype control immunoglobulin (IgG). Following the 16h supernatant incubation, the macrophages were stimulated with IFN-β for 3h. mRNA levels were normalized to GAPDH and made relative to the TNF-induced macrophage alone sample (part A) or IFN-induced macrophage with control media and IgG (part B), which were set to 100. The mean level of IFNB mRNA relative to GAPDH mRNA (% GAPDH) in part (A) was: coculture, 0.1%; transwell, 0.1%; supernatant, 0.1%; and the IFN-β-induced responses in part (B): CXCL10, 800%; IFIT1, 140%. Mean of n=4 donor experiments; error bars represent standard error (SE); ***<p=0.0001; **<p=0.001; *<p=0.05.